Alternative Epworth Sleepiness Scale ESS-ALT in French
SOMNOLD
Sleepiness in the Elderly: Validation of the Alternative Epworth Sleepiness Scale ESS-ALT in French
1 other identifier
observational
102
1 country
2
Brief Summary
The Epworth Sleepiness Scale (ESS) is undoubtedly the most commonly used tool in daily clinical practice to assess daytime sleepiness in patients of all ages by means of a self-administered questionnaire. In elderly subjects, the clinician is often confronted with difficulties in accurately estimating the ESS score and measuring subjective daytime sleepiness. Indeed, according to Onen et al, the ESS tends to underestimate the prevalence of sleep disorders in the geriatric population, mainly due to non-response to problematic items, namely:
- Item 3: Sitting, inactive in a public place (cinema, theater, meeting)
- Item 8: In a car that has been stopped for a few minutes. In order to overcome this problem, Janine Gronewold's German team has developed and begun work on the validation of an alternative version of the ESS, the ESS-ALT, adapted to the population of interest, in German. The aim of the present work is to adapt the ESS-ALT in French, then to study its correlation with sleep data recorded by nocturnal polysomnography, and among the secondary objectives, to correlate it with sleep latency during iterative sleep latency tests, in order to propose to the clinician a simple, reproducible tool, allowing to measure daytime sleepiness in elderly subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2023
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2023
CompletedFirst Posted
Study publicly available on registry
April 20, 2023
CompletedStudy Start
First participant enrolled
June 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2023
CompletedNovember 27, 2023
November 1, 2023
4 months
March 27, 2023
November 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validation of the alternative Epworth Daytime Sleepiness Scale -ALT adapted to the elderly and geriatric population in French
forward and backward translation" between English and French, and correlation with the ESS sleepiness scale.
24 hours
Secondary Outcomes (4)
Study of the correlation between the results of the French ESS-ALT and polysomnography data
24 hours
Study of the correlation between the results of the French ESS-ALT and MSLT (Multiple Sleep Latency Test) data
24 hours
intrinsic validity of the ESS-ALT in French
24 months
Study of the correlation between the ESS-ALT cohort in French and the ESS-ALT cohort in Germany
24 months
Study Arms (1)
Seniors with suspected sleep disorders referred for assessment
Seniors with suspected sleep disorders referred for assessment
Interventions
Seniors recruited into the study will test the Epworth Alternate Sleepiness Scale -ALT
Eligibility Criteria
Seniors with suspected sleep disorders referred for assessment
You may qualify if:
- Patient 65 years of age and older
- Consulting for sleep disorders
- Enrolled in a social security system or entitled to it
- Patient informed and having expressed his non-opposition to participate in the research
You may not qualify if:
- Severe psychiatric or cognitive disorders that do not allow the completion of examinations/questionnaires
- Patients who are dependent for all acts of daily life
- Patients with a very short life expectancy
- Patients under guardianship or curatorship
- Patients under AME
- Patients whose first language is not French
- Patients with visual or cognitive impairments that make reading impossible
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hospital Charles Foix
Ivry-sur-Seine, 94205, France
service des pathologies du sommeil, hôpital Pitié Salpêtrière
Paris, 75013, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2023
First Posted
April 20, 2023
Study Start
June 28, 2023
Primary Completion
October 19, 2023
Study Completion
October 20, 2023
Last Updated
November 27, 2023
Record last verified: 2023-11